840 related articles for article (PubMed ID: 23373626)
1. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
[TBL] [Abstract][Full Text] [Related]
2. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
Smith ER; McClain CD; Heeney M; Scott RM
Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
[TBL] [Abstract][Full Text] [Related]
3. Down syndrome and moyamoya: clinical presentation and surgical management.
See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
[TBL] [Abstract][Full Text] [Related]
4. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
Jea A; Smith ER; Robertson R; Scott RM
Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and long-term outcomes of moyamoya syndrome associated with neurofibromatosis type 1.
Han C; Yang WZ; Zhang HT; Ye T; Duan L
J Clin Neurosci; 2015 Feb; 22(2):286-90. PubMed ID: 25443089
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA
J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
[TBL] [Abstract][Full Text] [Related]
7. Surgical Treatment for Patients with Moyamoya Syndrome and Type 1 Neurofibromatosis.
Porras JL; Yang W; Garzon-Muvdi T; Xu R; Blakeley J; Belzberg A; Caplan JM; Khalid S; Colby GP; Coon AL; Tamargo RJ; Ahn ES; Huang J
World Neurosurg; 2017 Mar; 99():19-25. PubMed ID: 27876659
[TBL] [Abstract][Full Text] [Related]
8. Relative contributions of the middle meningeal artery and superficial temporal artery in revascularization surgery for moyamoya syndrome in children: the results of superselective angiography.
King JA; Armstrong D; Vachhrajani S; Dirks PB
J Neurosurg Pediatr; 2010 Feb; 5(2):184-9. PubMed ID: 20121368
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Moyamoya disease in the adult population with pial synangiosis.
Lin N; Aronson JP; Manjila S; Smith ER; Scott RM
J Neurosurg; 2014 Mar; 120(3):612-7. PubMed ID: 24405066
[TBL] [Abstract][Full Text] [Related]
10. Progression of disease in unilateral moyamoya syndrome.
Smith ER; Scott RM
Neurosurg Focus; 2008; 24(2):E17. PubMed ID: 18275294
[TBL] [Abstract][Full Text] [Related]
11. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications.
Funaki T; Takahashi JC; Takagi Y; Kikuchi T; Yoshida K; Mitsuhara T; Kataoka H; Okada T; Fushimi Y; Miyamoto S
J Neurosurg; 2015 Feb; 122(2):400-7. PubMed ID: 25423271
[TBL] [Abstract][Full Text] [Related]
12. Moyamoya syndrome and PHACE syndrome: clinical and radiographic characterization of the intracranial arteriopathy and response to surgical revascularization.
Jernigan S; Storey A; Hammer C; Riordan C; Orbach DB; Scott RM; Smith E
J Neurosurg Pediatr; 2019 Feb; 23(4):493-497. PubMed ID: 30717056
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
[TBL] [Abstract][Full Text] [Related]
14. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
Pandey P; Steinberg GK
J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
[TBL] [Abstract][Full Text] [Related]
15. [Pial synangiosis for moyamoya disease. The Bordeaux experience].
Jecko V; Penchet G; Champeaux C
Neurochirurgie; 2016 Aug; 62(4):190-6. PubMed ID: 27113323
[TBL] [Abstract][Full Text] [Related]
16. Pial synangiosis in patients with moyamoya younger than 2 years of age.
Jackson EM; Lin N; Manjila S; Scott RM; Smith ER
J Neurosurg Pediatr; 2014 Apr; 13(4):420-5. PubMed ID: 24527861
[TBL] [Abstract][Full Text] [Related]
17. Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases.
Kennedy BC; McDowell MM; Yang PH; Wilson CM; Li S; Hankinson TC; Feldstein NA; Anderson RC
Neurosurg Focus; 2014 Jan; 36(1):E12. PubMed ID: 24380478
[TBL] [Abstract][Full Text] [Related]
18. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
20. Discovery of asymptomatic moyamoya arteriopathy in pediatric syndromic populations: radiographic and clinical progression.
Lin N; Baird L; Koss M; Kopecky KE; Gone E; Ullrich NJ; Scott RM; Smith ER
Neurosurg Focus; 2011 Dec; 31(6):E6. PubMed ID: 22133171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]